In a Conference Call back in the first half of 201

In a Conference Call back in the first half of 2014 I remember Dr. Lowe talking about MANF/Diabetes. We were all excited after the Urano/Wolframs deal thinking a Big Pharma deal was imminent. I was surprised to hear the way Lowe talked about our position regarding it. He acknowledged MANF and Diabetes are huge, but he said we were primarily a Parkinson's research company and really needed to consult with diabetes experts before we know what direction to go it. (Paraphrasing) I was surprised by his comments. It opened my eyes to the limits of our expertise and to the fraudulence of watson's claims. Nearly a year has gone by since that CC and there have been no developments on the diabetes front.

That isn't to say Urano may not turn back to recombinant MANF as his primary focus on wolframs and thus diabetes.....but that hasn't happened yet. Watson is a flipper/trader and profits from the gyrations he causes with shareholders by his phony and grandiose predictions....which never come true... only serving to dishearten many over why Gerald never produces !! Gerald has done pretty well, but both Gerald and watson have contributed to unrealistic expectations.